Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
113 * !
|
Mon, 7/31/2017,
8:30 AM -
10:20 AM
|
CC-317
|
|
Clinical Outcome Assessments: Measurement, Evaluation, and Interpretation — Topic Contributed Papers
|
|
Biopharmaceutical Section
|
|
Organizer(s): Xu Shu, Novartis
|
|
Chair(s): Dong Xi, Novartis Pharmaceuticals Corporation
|
|
8:35 AM
|
Generalizability Theory for Clinician-Rated Outcomes
—
Joseph Cappelleri, Pfizer Inc
|
|
8:55 AM
|
Exploring the Cognitive Endpoints in Alzheimer's Disease Cohort Data Using Item Response Theory Models
—
Xu Shu, Novartis
|
|
9:15 AM
|
Estimating Real Cigarette Counts from Heaped Time-Line Follow-Back Data
—
Chelsea McCarty Allen, Southern Methodist University ; Daniel F. Heitjan, Southern Methodist University
|
|
9:35 AM
|
Patient-Reported Outcomes: Observations of Regulatory Approvals by the Center for Biologics Evaluation and Research
—
Hussein Ezzeldin, FDA/CBER ; Megan Moncur, FDA/CBER ; Yuqun Abigail Luo, FDA/CBER ; Telba Irony, Office of Biostatistics and Epidemiology, CBER, FDA
|
|
9:55 AM
|
Mixed Methods for Analyzing Factors Important to Patients in Choosing a Dialysis Modality
—
Jarcy Zee, Arbor Research Collaborative for Health ; Lalita Subramanian, Arbor Research Collaborative for Health ; Junhui Zhao, Arbor Research Collaborative for Health ; Francesca Tentori, Arbor Research Collaborative for Health; Vanderbilt University
|
|
10:15 AM
|
Floor Discussion
|
|
